Human ASPH/AAH/BAH ORF/cDNA clone-Lentivirus particle (NM_001164756)

Cat. No.: vGMLP002035

Pre-made Human ASPH/AAH/BAH Lentiviral expression plasmid for ASPH lentivirus packaging, ASPH lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to ASPH/AAH products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP002035 Human ASPH Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP002035
Gene Name ASPH
Accession Number NM_001164756
Gene ID 444
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 612 bp
Gene Alias AAH,BAH,CASQ2BP1,FDLAB,HAAH,JCTN,junctin
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCCCAGCGTAAGAATGCCAAGAGCAGCGGCAACAGCAGCAGCAGCGGCTCCGGCAGCGGTAGCACGAGTGCGGGCAGCAGCAGCCCCGGGGCCCGGAGAGAGACAAAGCATGGAGGACACAAGAATGGGAGGAAAGGCGGACTCTCAGGAACTTCATTCTTCACGTGGTTTATGGTGATTGCATTGCTGGGCGTCTGGACATCTGTAGCTGTCGTTTGGTTTGATCTTGTTGACTATGAGGAAGTTCTAGCCAAAGCAAAGGACTTCCGTTATAACTTATCAGAGGTGCTTCAAGGAAAACTAGGAATCTATGATGCTGATGGTGATGGAGATTTTGATGTGGATGATGCCAAAGTTTTATTAGGCCTGACCAAAGATGGCAGTAATGAAAATATTGATTCTCTTGAGGAAGTCCTTAATATTTTAGCAGAGGAAAGTTCAGATTGGTTTTATGGTTTCCTCTCATTTCTCTATGATATAATGACTCCTTTTGAAATGCTAGAAGAAGAAGAAGAAGAAAGCGAAACCGCAGATGGTGTTGATGGTACGTCACAGAATGAAGGGGTTCAGGGAAAGACTTGTGTCATATTGGATTTACATAACCAGTAA
ORF Protein Sequence MAQRKNAKSSGNSSSSGSGSGSTSAGSSSPGARRETKHGGHKNGRKGGLSGTSFFTWFMVIALLGVWTSVAVVWFDLVDYEEVLAKAKDFRYNLSEVLQGKLGIYDADGDGDFDVDDAKVLLGLTKDGSNENIDSLEEVLNILAEESSDWFYGFLSFLYDIMTPFEMLEEEEEESETADGVDGTSQNEGVQGKTCVILDLHNQ

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T52133-Ab Anti-ASPH/ AAH/ BAH monoclonal antibody
    Target Antigen GM-Tg-g-T52133-Ag ASPH VLP (virus-like particle)
    ORF Viral Vector pGMLP002035 Human ASPH Lentivirus plasmid
    ORF Viral Vector vGMLP002035 Human ASPH Lentivirus particle


    Target information

    Target ID GM-T52133
    Target Name ASPH
    Gene Group Identifier
    （Target Gene ID in Homo species)         		444
    Gene ID 100065909 (Equus caballus), 105260207 (Felis catus), 286771 (Bos taurus), 312981 (Rattus norvegicus)
    403846 (Canis lupus familiaris), 444 (Homo sapiens), 65973 (Mus musculus), 699884 (Macaca mulatta)
    Gene Symbols & Synonyms ASPH,Asph,AAH,BAH,HAAH,JCTN,FDLAB,junctin,CASQ2BP1,cI-37,2310005F16Rik,3110001L23Rik
    Target Alternative Names 2310005F16Rik,3110001L23Rik,AAH,ASPH,Aspartate beta-hydroxylase (ASP beta-hydroxylase),Aspartyl/asparaginyl beta-hydroxylase,Asph,BAH,CASQ2BP1,FDLAB,HAAH,JCTN,Peptide-aspartate beta-dioxygenase,cI-37,junctin
    Uniprot Accession Q12797,Q28056,Q8BSY0
    Additional SwissProt Accessions: Q28056,Q12797,Q8BSY0
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target, Immuno-oncology Target
    Disease
    Disease from KEGG Calcium signaling pathway
    Gene Ensembl ENSECAG00000021447, ENSBTAG00000026283, ENSCAFG00845029184, ENSG00000198363, ENSMUSG00000028207, ENSMMUG00000008777
    Target Classification Checkpoint-Immuno Oncology


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.